QUIKHALE FB 200 INHALER

How QUIKHALE FB 200 INHALER Works

• QUIKHALE FB 200 INHALER is a combination medication containing two active ingredients: Formoterol and Budesonide. These components work synergistically to alleviate the symptoms of asthma and chronic obstructive pulmonary disease (COPD), providing both bronchodilation and anti-inflammatory effects.
• Formoterol is a long-acting beta-2 adrenergic agonist (LABA). It works by selectively stimulating beta-2 adrenergic receptors in the smooth muscle of the airways. This stimulation leads to the activation of adenylate cyclase, an enzyme that increases the production of cyclic AMP (cAMP). Increased levels of cAMP cause the smooth muscle in the airways to relax, resulting in bronchodilation. This bronchodilation helps to open up the airways, making it easier to breathe. The effects of formoterol are long-lasting, providing relief from bronchospasm for up to 12 hours.
• Budesonide is a corticosteroid with potent anti-inflammatory properties. When inhaled, budesonide reduces inflammation in the airways by inhibiting the release of inflammatory mediators such as cytokines and chemokines. It also reduces the infiltration of inflammatory cells like eosinophils and mast cells into the airway tissues. By suppressing inflammation, budesonide helps to reduce swelling, mucus production, and hyperreactivity of the airways. This makes the airways less sensitive to triggers that can provoke asthma or COPD symptoms.
• The combined action of formoterol and budesonide addresses both the bronchoconstriction and inflammation aspects of respiratory diseases. Formoterol provides rapid and sustained bronchodilation to relieve acute symptoms like wheezing and shortness of breath, while budesonide works to control the underlying inflammation that contributes to chronic symptoms and exacerbations. Regular use of QUIKHALE FB 200 INHALER helps to improve lung function, reduce the frequency and severity of symptoms, and enhance the overall quality of life for individuals with asthma or COPD. It is crucial to use this medication as prescribed by your healthcare provider for optimal therapeutic benefits.
• In summary, QUIKHALE FB 200 INHALER delivers formoterol to relax airway muscles for easier breathing and budesonide to reduce airway inflammation. This dual action helps manage and control asthma and COPD symptoms effectively.

Like all medicines, QUIKHALE FB 200 INHALER can cause side effects, although not everybody gets them. **Common Side Effects (may affect up to 1 in 10 people):** * Headache * Tremor (shaking) * Palpitations (fast or irregular heartbeat) * Cough * Hoarseness * Sore throat * Oral thrush (a fungal infection in the mouth) **Uncommon Side Effects (may affect up to 1 in 100 people):** * Muscle cramps * Anxiety * Restlessness * Sleep disturbances * Dizziness * Changes in taste * Nausea * Diarrhea * Indigestion * Skin rash * Itching * Increased sweating * Increased blood sugar levels **Rare Side Effects (may affect up to 1 in 1,000 people):** * Paradoxical bronchospasm (sudden wheezing or difficulty breathing immediately after using the inhaler - stop using the inhaler and seek immediate medical help) * Angioedema (swelling of the face, lips, tongue, or throat) * Decreased bone density * Glaucoma (increased pressure in the eye) * Cataracts **Very Rare Side Effects (may affect up to 1 in 10,000 people):** * Changes in blood pressure * Hyperactivity * Depression * Aggression **Frequency Not Known (cannot be estimated from the available data):** * Irregular heartbeat * Chest pain **Important Information:** * This is not a complete list of all possible side effects. If you experience any other unusual symptoms, consult your doctor or pharmacist. * Tell your doctor immediately if you experience any severe side effects, especially breathing difficulties, chest pain, or allergic reactions.

• If you miss a dose of QUIKHALE FB 200 INHALER, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double your dose to make up for a missed one.

• Keep QUIKHALE FB 200 INHALER away from the reach of children and pets.
• Store QUIKHALE FB 200 INHALER in a refrigerator (2 - 8°C). Do not freeze.

• **Use as Prescribed:** Always use QUIKHALE FB 200 INHALER exactly as your doctor has told you. Do not increase the dose or use it more frequently without consulting them, as this can increase the risk of side effects. Consistent, prescribed use is key to managing your respiratory condition effectively.
• **Prime the Inhaler Properly:** Before using a new QUIKHALE FB 200 INHALER, or if you haven't used it for more than a week, prime it by releasing a few test sprays into the air, away from your face. This ensures that you receive the correct dose of medication when you use it. Check the inhaler's instructions for specific priming details.
• **Inhale Correctly for Best Results:** To get the most out of each dose, exhale fully, then place the mouthpiece in your mouth and seal your lips around it. As you start to inhale slowly and deeply, press down on the canister to release the medication. Continue inhaling deeply, then hold your breath for about 10 seconds before exhaling slowly. This allows the medication to reach deep into your lungs.
• **Rinse Your Mouth After Use:** After using QUIKHALE FB 200 INHALER, rinse your mouth thoroughly with water without swallowing. This helps to prevent oral thrush (a fungal infection) and reduces the likelihood of a sore throat. Good oral hygiene is an important part of your treatment.
• **Clean Your Inhaler Regularly:** Clean your QUIKHALE FB 200 INHALER at least once a week, or more often if needed. Remove the canister and rinse the plastic actuator with warm water. Allow it to air dry completely before reassembling and storing. A clean inhaler ensures proper hygiene and prevents blockage that can affect dosage accuracy.

• QUIKHALE FB 200 INHALER is generally safe to use with food. There are no known significant food interactions. You can use the inhaler before or after meals without affecting its efficacy.